Skip to Content
Søg Menu

ASCO 2019: The first gene expression analysis of patients with advanced breast cancer treated with ribociclib-containing therapy

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

Agnethe Langborg Rudbeck

FDG-PET/CT-scanning ændrer sygdomsstadie ved brystkræft

/ Agnethe Langborg Rudbeck
DSKO25Brystcancer Play the Video 01:58
Per Hall

Making Primary Breast Cancer Prevention a Reality

/ Per Hall
Brystcancer Play the Video 03:48
Philip Poortmans

Breast Cancer Treatment: The Role of Boost Radiation Therapy in Reducing Recurrence Risks

/ Philip Poortmans
Onkologisk Forum 2024Brystcancer Play the Video 06:45
Demet Özcan

Breast Cancer: The Prognostic Value of Tumor-Infiltrating Lymphocytes

/ Demet Özcan
SABCS24Brystcancer Play the Video 06:43
Hope Rugo

Abemaciclib Shows Significant Benefit for HR-Positive HER2-Negative Patients with Advanced Breast Cancer

/ Hope S. Rugo
Brystcancer Play the Video 11:57
Maren Marie Andreassen

MRI-Based AI Can Detect Responsive Treatment of Breast Cancer After Three Weeks of Therapy

/ Maren Marie Andreassen
NBCNBrystcancer Play the Video 02:20
Adam Brufsky

SABCS 2024: Palbociclib, Abemaciclib, and Ribociclib Can Be Considered Equivalent in the Treatment of HR-positive/HER2-negative Metastatic Breast Cancer

/ Adam Brufsky
SABCS24Brystcancer Play the Video 08:56
Stefania Katrin Finnsdottir

The Need to Improve Compliance with Adjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer

/ Stefanía Katrín Finnsdóttir
NBCNBrystcancer Play the Video 02:45
Minna Tanner

The Approval of New Drugs Should Be Harmonized Across the Nordic Countries

/ Minna Tanner
NBCNBrystcancer Play the Video 03:20
Back to top